Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)

HNX:MKV Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2019
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2019
Cash & Equivalents	4,092	14,417	15,175	9,192	4,177	1,794
Short-Term Investments	36,500	18,000	6,000	6,000	6,000	-
Cash & Short-Term Investments	40,592	32,417	21,175	15,192	10,177	1,794
Cash Growth	107.32%	53.09%	39.38%	49.27%	467.45%	81.05%
Accounts Receivable	20,267	24,861	38,006	32,952	23,406	23,502
Other Receivables	8,693	941.61	135.38	133.18	317.3	264.52
Receivables	28,960	34,803	38,141	33,085	23,724	23,767
Inventory	22,652	18,204	16,642	12,990	28,663	13,285
Prepaid Expenses	809.66	513.6	370.88	560.72	832.17	476.83
Other Current Assets	671.25	1,608	657.98	115.53	1,516	518.57
Total Current Assets	93,685	87,546	76,987	61,943	64,912	39,840
Property, Plant & Equipment	25,974	27,094	30,128	34,359	40,545	64,615
Other Intangible Assets	-	-	-	-	-	34.92
Long-Term Deferred Tax Assets	1,049	1,049	1,771	1,216	-	-
Other Long-Term Assets	502.53	358.84	602.9	808.53	586.42	308.38
Total Assets	121,210	116,048	109,489	98,326	106,044	104,798

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2019
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2019
Accounts Payable	3,164	1,292	1,537	4,829	5,723	3,011
Accrued Expenses	11,067	10,429	20,066	12,004	6,485	4,560
Short-Term Debt	-	-	-	-	18,405	26,698
Current Income Taxes Payable	561.78	62.07	427.25	1,431	217.89	935.24
Other Current Liabilities	163.41	228.69	312.19	240.47	92.79	1,547
Total Current Liabilities	14,956	12,012	22,343	18,504	30,924	36,752
Long-Term Debt	-	-	-	-	-	15,099
Other Long-Term Liabilities	-	-	-	-	1,500	-
Total Liabilities	14,956	12,012	22,343	18,504	32,424	51,850

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2019
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2019
Common Stock	50,000	50,000	50,000	50,000	50,000	50,000
Retained Earnings	56,254	54,036	37,146	29,822	23,620	2,948
Treasury Stock	-0.38	-0.38	-0.38	-0.38	-0.38	-0.38
Shareholders' Equity	106,254	104,036	87,146	79,822	73,620	52,948
Total Liabilities & Equity	121,210	116,048	109,489	98,326	106,044	104,798

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2019
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2019
Total Debt	-	-	-	-	18,405	41,797
Net Cash (Debt)	40,592	32,417	21,175	15,192	-8,227	-40,003
Net Cash Growth	107.32%	53.09%	39.38%	-	-	-
Net Cash Per Share	8124.06	6483.48	4235.00	3038.35	-1645.72	-
Filing Date Shares Outstanding	5	5	5	5	5	-
Total Common Shares Outstanding	5	5	5	5	5	-
Working Capital	78,729	75,534	54,644	43,439	33,988	3,089
Book Value Per Share	21250.83	20807.24	17429.19	15964.32	14726.40	-
Tangible Book Value	106,254	104,036	87,146	79,822	73,620	52,913
Tangible Book Value Per Share	21250.83	20807.24	17429.19	15964.32	14726.40	-
Buildings	36,888	36,888	36,888	36,888	-	-
Machinery	65,473	64,381	65,205	65,205	-	-
Construction In Progress	-	82	-	-	233.28	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 30, 2026

Data Sources Report a data error